HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Calcium supplementation for the prevention of hypertensive disorders of pregnancy: current evidence and programmatic considerations.

Abstract
Most low- and middle-income countries present suboptimal intakes of calcium during pregnancy and high rates of mortality due to maternal hypertensive disorders. Calcium supplementation during pregnancy is known to reduce the risk of these disorders and associated complications, including preeclampsia, maternal morbidity, and preterm birth, and is, therefore, a recommended intervention for pregnant women in populations with low dietary calcium intake (e.g., where ≥25% of individuals in the population have intakes less than 800 mg calcium/day). However, this intervention is not widely implemented in part due to cost and logistical issues related to the large dose and burdensome dosing schedule (three to four 500-mg doses/day). WHO recommends 1.5-2 g/day but limited evidence suggests that less than 1 g/day may be sufficient and ongoing trials with low-dose calcium supplementation (500 mg/day) may point a path toward simplifying supplementation regimens. Calcium carbonate is likely to be the most cost-effective choice, and it is not necessary to counsel women to take calcium supplements separately from iron-containing supplements. In populations at highest risk for preeclampsia, a combination of calcium supplementation and food-based approaches, such as food fortification with calcium, may be required to improve calcium intakes before pregnancy and in early gestation.
AuthorsFilomena Gomes, Per Ashorn, Sufia Askari, Jose M Belizan, Erick Boy, Gabriela Cormick, Katherine L Dickin, Amalia R Driller-Colangelo, Wafaie Fawzi, G Justus Hofmeyr, Jean Humphrey, Anuradha Khadilkar, Rubina Mandlik, Lynnette M Neufeld, Cristina Palacios, Daniel E Roth, Julie Shlisky, Christopher R Sudfeld, Connie Weaver, Megan W Bourassa
JournalAnnals of the New York Academy of Sciences (Ann N Y Acad Sci) Vol. 1510 Issue 1 Pg. 52-67 (04 2022) ISSN: 1749-6632 [Electronic] United States
PMID35000200 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2022 The Authors. Annals of the New York Academy of Sciences published by Wiley Periodicals LLC on behalf of New York Academy of Sciences.
Chemical References
  • Calcium, Dietary
  • Calcium
Topics
  • Calcium (therapeutic use)
  • Calcium, Dietary (therapeutic use)
  • Dietary Supplements
  • Female
  • Humans
  • Hypertension, Pregnancy-Induced (prevention & control)
  • Infant, Newborn
  • Pre-Eclampsia (prevention & control)
  • Pregnancy
  • Premature Birth

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: